This study specifically examines the RNA interference pathway regulators, particularly DICER1, to uncover its potential as a novel biomarker and therapeutic target in breast cancer (Zhang et al., 2024; Juul et al., 2010; Fang et al., 2022). Here, DICER1 is linked to breast cancer.